ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings

Penzias, Gregory*; Singanamalli, Asha; Elliott, Robin; Gollamudi, Jay; Shih, Natalie; Feldman, Michael; Stricker, Phillip D.; Delprado, Warick; Tiwari, Sarita; Bohm, Maret; Haynes, Anne-Maree; Ponsky, Lee; Fu, Pingfu; Tiwari, Pallavi; Viswanath, Satish; Madabhushi, Anant*河北医科大学
PLoS One2018-8-31DOI: 10.1371/journal.pone.0200730
44被引3阅读
引用收藏
分享

摘要

Translation of radiomics into the clinic may require a more comprehensive understanding of the underlying morphologic tissue characteristics they reflect. In the context of prostate cancer (PCa), some studies have correlated gross histological measurements of gland lumen, epithelium, and nuclei with disease appearance on MRI. Quantitative histomorphometry (QH), like radiomics for radiologic images, is the computer based extraction of features for describing tumor morphology on digitized tissue images. In this work, we attempt to establish the histomorphometric basis for radiomic features for prostate cancer by (1) identifying the radiomic features from T2w MRI most discriminating of low vs. intermediate/high Gleason score, (2) identifying QH features correlated with the most discriminating radiomic features previously identified, and (3) evaluating the discriminative ability of QH features found to be correlated with spatially co-localized radiomic features. On a cohort of 36 patients (23 for training, 13 for validation), Gabor texture features were identified as being most predictive of Gleason grade on MRI (AUC of 0.69) and gland lumen shape features were identified as the most predictive QH features (AUC = 0.75). Our results suggest that the PCa grade discriminability of Gabor features is a consequence of variations in gland shape and morphology at the tissue level.

学科与关键词

关键词
WHOLE HISTOLOGICAL SECTIONSTEXTURE ANALYSISTISSUE COMPOSITIONCENTRAL GLANDIMAGESADENOCARCINOMAHISTOPATHOLOGYCLASSIFICATIONSEGMENTATIONMODELS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PLoS One
发表日期
2018-08-31
卷期
第 13 卷, 第 8 期
页码
e0200730
DOI
10.1371/journal.pone.0200730
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01M, R01 CA216579-01A1, R01 CA220581-01A1, R21CA179327-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21CM 95152-01, R01DK098503-02]; National Center for Research Resources [1 C06 RR12463-01]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; DOD career development award [W81XWH-16-1-0329]; Ohio Third Frontier Technology Validation Fund; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; NIH [RO1]; National Cancer Institute [R01CA208236] Funding Source: NIH RePORTER

作者

  • P

    Penzias, Gregory (通讯) (第一作者)

  • S

    Singanamalli, Asha

查看全部 16 位作者收起作者
  • E

    Elliott, Robin

  • G

    Gollamudi, Jay

  • S

    Shih, Natalie

  • F

    Feldman, Michael

  • S

    Stricker, Phillip D.

  • D

    Delprado, Warick

  • T

    Tiwari, Sarita

    inst med

  • B

    Bohm, Maret

    inst med

  • H

    Haynes, Anne-Maree

    inst med

  • P

    Ponsky, Lee

  • F

    Fu, Pingfu

  • T

    Tiwari, Pallavi

  • V

    Viswanath, Satish

  • M

    Madabhushi, Anant (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417